Answers are grounded in this paper and cite their sources.
Coronavirus SARS-CoV-2 disease (COVID-19) is characterized by severe and high mortality, which increases significantly with age. This poses a great threat to the elderly. The results of numerous clinical observations suggest that the interaction of drugs used in the COVID-19 treatment and concomitant pathology in elderly patients may worsen the course of the disease and lead to the development of serious complications. Therefore, a need for an individual approach to treatment. Appropriate adjustment of the doses of prescribed drugs and taking into account the interaction of drugs for the treatment of concomitant pathology will help to increase the effectiveness of COVID-19 drug therapy in the elderly.
No takes yet. Share an insight, caveat, or question.
Bezrukov et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: